Management and prognosis of acute liver failure in children

Current Gastroenterology Reports

Volumn 14, Issue 3, 2012, Pages 262-269

  D'Agostino, Daniel ^a   Diaz, Silvia ^a   Sanchez, Maria Camila ^a   Boldrini, Gustavo ^a  

^a HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

Acute liver failure; Children; Hepatic encephalopathy; Hypothermia; Liver transplantation; MELD PELD

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIPYRETIC AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; DOPAMINE; LIDOCAINE; MANNITOL; NORADRENALIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RIFAXIMIN; SODIUM CHLORIDE;

ACUTE LIVER FAILURE; BLOOD CLOTTING DISORDER; CHILD; CLINICAL PROTOCOL; DOPPLER ECHOGRAPHY; ELECTROENCEPHALOGRAPHY; GENE EXPRESSION; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; HYPEREMIA; INDUCED HYPOTHERMIA; INFLAMMATION; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE MONITORING; LIVER TRANSPLANTATION; MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLASMAPHERESIS; PROGNOSIS; REVIEW;

BLOOD COAGULATION DISORDERS; CHILD; HEPATIC ENCEPHALOPATHY; HUMANS; INTRACRANIAL PRESSURE; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; MONITORING, PHYSIOLOGIC; PATIENT SELECTION; PROGNOSIS;

EID: 84861095555     PISSN: 15228037     EISSN: 1534312X     Source Type: Journal    
DOI: 10.1007/s11894-012-0260-x     Document Type: Review

References (58)

1. Lee WS, McKierman P, Keely DA. Etiology, outcome, and prognostic indication of Childhood fulminant hepatic failure in United Kingdom. Pediatr Gastroenterol Nutr 2005, 575-581 (Pubitemid 40617185)
2. Farmer DG, Venick RS, McDiarmid SV et al. Fulminant Hepatic Failure in children: Superior and durable outcome with liver transplantation over 25 years at a single center. Ann Surg 2009; 250(3) 484-493.
3. Munne MS, Altabert NR, Vladimisky SN, et al. Identifications of polyhyletic variants in acute hepatitis suggest an under diagnosed circulation of hepatitis E virus in Argentina. JClin Virol. 2011;52 (2):138-41.
4. Sundaram SS, Alonso EM, Narkewicz MR, Zhang S, Squires RH. Pediatric Acute Liver Failure Study Group. Characterization and outcomes of young infants with acute liver failure. J Pediatr. 2011;159(5):813-8.
5. Ciocca M, Ramonet M, Cuarterolo M, Lopez S, Cernadas C, Alvarez F. Prognosis Factors in pediatric acute liver failure. Arch Dis Child. 2008;03:48-51.
6. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010;376(9736):190-201.
7. Larsen FS, Wendon J. Prevention and management of brain edema in patients with Acute Liver Failure. Liver Transpl. 2008;14:90-6.
8. Clemmensen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology. 1999;29:648-53. (Pubitemid 29109575)
9. Jiang W, Desjardins P, Butterworth RF. Cerebral inflammation contributes to encephalopathy and brain edema in acute liver failure: protective effect of minocycline. J Neurochem. 2009;109:485-93.
10. Fiore M, Probert L, Kollia G, Akassoglou K, et al. Neurobehavioral alterations in developing transgenic mice espressing TNF-alpha in the brain. Brain Behav Immun. 1996;10:126-38. (Pubitemid 26320888)
11. Krueger J, Fang J, Taishi P, Chen Z, et al. Sleep A physiologic role for IL-1 beta and TNF- alpha. Ann NY Acad Sci. 1998;856:148-59. (Pubitemid 128713055)
12. AllanS and RothwellN. Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2001; 2, 734-744. (Pubitemid 33674819)
13. Petty and Lo E. Functional complexes of the blood- brain barrier: permeability changes in neuroinflammation. Prog. Neurobiol.2002; 68, 311-323. (Pubitemid 36071509)
14. Andersson A, Ronnback L, Hansson E. Lactate induce tumor necrosis factor- alpha, interleukin-6 and interleukin-1 beta release in microglial and astroglial - enriched primary cultures. J Neurochem. 2005;93:1327-33.
15. Haussinger D. Low grade cerebral edema and the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology. 2006;43:1187-90. (Pubitemid 43980095)
16. Vaquero J, Rose C, Butterworth R. Keeping cool in acute liver failure: Rationale for the use of mild hypothermia. Vaquero J, Rose C, Butterworth R. J Hepatol. 2005;43:1067-77. (Pubitemid 41627994)
17. Muñoz S, Rajender Reddy K, Lee W. The coagulopathy of acute liver failure and implications for intracranial monitoring. Neurocrit Care. 2008;9:103-7.
18. Mahajan A, Lat I. Correction of coagulopathy in the setting of acute liver failure. Crit Care Nurs Clin N Am. 2010;22:315-21.
19. Stravitz R, Kramer A, Darven T, Shaikh O, et al. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med. 2007;35:2498-508. (Pubitemid 351339009)
20. Bhatia V, Batra Y, Subrat Kumar A. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure a controlled clinical trial. J Hepatol. 2004;41:89-96. (Pubitemid 39005158)
21. Starvitz R, Larsen F. Therapeutic hypothermia for acute liver failure. Crit Care Med 2009; 37: S258-S264.
22. Jacob S, Khan A, Jacobs E, Kandiah P, et al. Prolonged hypothermia as a bridge to recovery for cerebral edema and intracranial hypertension associated with fulminant hepatic failure. Neurocrit Care. 2009;11:242-6.
23. Dmello D, Cruz-Flores S, Matuschak GM. Moderate hypothermia with intracranial pressure monitoring as a therapeutic paradigm for the management of acute liver failure: A systematic review. Intensive Care Med. 2010;36:210-3.
24. Cochran JB, Losek JB. Acute Liver Failure in children. Pediatr Emerg Care. 2007;23(2):129-35. (Pubitemid 46398947)
25. Nadalin S, Heuer M, Wallot M, et al. Paediatric acute liver failure and transplantation: The University of Essen experience. Transpl Int. 2007;20(6):519-27. (Pubitemid 46701079)
26. Phua J, Lee KH. Liver support devices. Curr Opin Crit Care. 2008;14:208-15. (Pubitemid 351498788)
27. Sasbon JS, Devictor D, Tissieres P. Liver support for fulminant hepatic failure: Is it time to use the Molecular Adsorbents Recycling System in children? Pediatr Crit Care Medicine. 2005;6 (5):585-91. (Pubitemid 41306763)
28. Arora G, Keeffe EB. Management of chronic liver failure until liver transplantation. Med Clin North Am. 2008;92:839,ix-60,ix.
29. Tissieres P, Sasbon JS, Devictor D. Liver support for fulminant hepatic failure: is it time to use the Molecular Adsorbents Recycling System in children? Pediatr Crit Care Med. 2005;6:585-91. (Pubitemid 41306763)
30. Liu JP, Gluud LL, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for liver failure. Cochrane Database Syst Rev 2004;(1):CD003628
31. Devictor D, Tissieres P, Afanetti M, Debray D. Acute liver failure in children. Clinics and Research in Hepatology and Gastroenterology. 2011;35:430-7.
32. Faraj W, Dar F, Bartlet A, Vilcamelendez H, Marangoni G, Mielivergani G, Dhawan A and Rela M. Auxiliary Liver Transplantation for Acute Liver Failure in Children. Ann Surg. 2010;251(2):351-6.
33. Dhiman R, Jain S, Masheshawri U, et al. Early indicators of prognosis in Fulminant Hepatic Failure: An assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital Criteria. Liver Transpl. 2007;13:814-21. (Pubitemid 46939435)
34. O'Grady JG. Prognostication in acute liver failure: a tool or an anchor? Liver Transpl. 2007;13:786-7. (Pubitemid 46939431)
35. O'Grady JG, Graeme JM, Hayllar KM, et al. Early indicators of prognosis infulminant hepatic failure. Gastroenterology. 1989;97:439-45. (Pubitemid 19192181)
36. Bernuau J, Benhamou JP. Fulminant and subfulminant liver failure. In: McIntyre N, Benhamou JP, Bircher J, Rizzeto M, Rodes J, editors. Oxford Textbook of Clinical. Hepatology. Oxford: Oxford Medical Publications, 1991: 923-942.
37. Bernuau J, Goudeau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986;6:648-51. (Pubitemid 16038182)
38. Yantorno S, Kremers W, Ruf A, et al. MELD is superior to King's College and Clichy's Criteria to assess prognosis in fulminant hepatic failure. Transplantation. 2007;13:822-8. (Pubitemid 46939436)
39. Sanchez M and D'Agostino D. Pediatric end-stage liver disease score in acute liver failure to assess poor prognosis. J Pediatr Gastroenterol Nutr. 2011 Aug 30.
40. Squires Jr. RH, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr. 2006;148:652-8.
41. Squires RH, Sokol RJ, Schneider BL, et al. Encephalopathy at presentation predicts outcome for children with acute liver failure. Abstract Hepatology. 2002;36:167A.
42. Tissieres P, Prontera W, Chevret L, et al. The pediatric risk of mortality score in infants and children with fulminant liver failure. Pediatr Transplant. 2003;7:64-8. (Pubitemid 36314193)
43. Dhawan A, Cheeseman P, Mieli-Vergani G. Approaches to liver failure in children. Pediatr Transplant. 2004;8:584-8.
44. Lu B, Gralla J, Liu E, et al. Evaluation of a scoring system for assessing prognosis in pediatric acute liver failure. Clin Gastroenterol Hepatol. 2008;6:1140-5.
45. Bernal W, Wendon J, Rela M. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology. 1998;27:1050-5. (Pubitemid 28160491)
46. Harrison PM, O'Grady JG, Keays RT, et al. Serial prothrombin time as prognostic indicator in paracetamol induced fulminant hepatic failure. Br Med J. 1990;301:964-6. (Pubitemid 20362194)
47. Pereira LM, Langley PG, Hayllar KM, et al. Coagulation factor V and VIII/V ratio as predictors of outcome in paracetamol induced fulminant hepatic failure: relation to other prognostic indicators. Gut. 1992;33:98-102.
48. Hoofnagle JH, Carithers RL, Shapiro C, et al. Fulminant hepatic failure: summary of a workshop. Hepatology. 1995;21:240-52.
49. Murray-Lyon IM, Orr AH, Gazzard B, et al. Prognostic value of serum alphafetoprotein in fulminant hepatic failure including patients treated by charcoal haemoperfusion. Gut. 1976;17:576-80.
50. Macquillan GC, Seyam MS, Nightingale P, et al. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transpl. 2005;11:1073-9. (Pubitemid 41341756)
51. Schmidt LE, Dalhoff K. Serum phosphate is an early predictor of outcome in severe acetaminophen-induced hepatotoxicity. Hepatology. 2002;36:659-65. (Pubitemid 34977176)
52. BernalW, Donaldson N,Wyncoll D, et al. Blood lactate as an early predictor of outcome in paracetamolinduced acute liver failure: a cohort study. Lancet. 2002;359:558-63. (Pubitemid 34178437)
53. Ranek L, Andreasen PB, Tygstrup N. Galactose elimination capacity as a prognostic index in patients with fulminant liver failure. Gut. 1976;17:959-64.
54. Bhatia V, Singh R, Acharya SK. Predictive value of arterial ammonia for complications and outcome in acute liver failure. Gut. 2006;55:98-104. (Pubitemid 41820642)
55. Lee WM, Galbraith RM, Watt GH, et al. Predicting survival in fulminant hepatic failure using serum Gc protein concentrations. Hepatology. 1995;21:101-5.
56. Schiøt FV, Bangert K, Shakil AO. Predictive value of actin-free Gc-globulin in acute liver failure. Liver Transpl. 2007;13:1324-9. (Pubitemid 47457062)
57. Donaldson BW, Gopinath R, Wanless IR, et al. The role of transjugular liver biopsy in fulminant liver failure: relation to other prognostic indicators. Hepatology. 1993;18:1370-4. (Pubitemid 23348424)
58. Malinchoc M, Kamath PS, Gordon FD, et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;3:864-71. (Pubitemid 30169932)